Canaccord analyst Jason Tilchen lowered the firm’s price target on Stride (LRN) to $125 from $175 and keeps a Buy rating on the shares. The firm said they reported mixed Q1 results, with total enrollment coming in slightly below expectations while revenue and profitability modestly exceeded consensus. Application volumes remained strong throughout the enrollment period, although an upgrade of the company’s learning and tech platforms intended to support current and future enrollment growth encountered significant implementation challenges at the start of the school year.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRN:
- Stride’s Long-Term Potential Remains Intact Despite Short-Term Challenges
- Stride downgraded to Market Perform from Outperform at BMO Capital
- BMO downgrades Stride on ‘disappointing’ fiscal 2026 outlook
- Stride, Inc. Reports Strong Q1 2026 Financial Growth
- Closing Bell Movers: Bloom Energy, Teradyne both up 20% on earnings